Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
This timeline is based on the normal pace of Phase 3 data analysis, regulatory submission preparation, and FDA review processes
Karachaliou CE, Livaniou E (2023) Neuroprotective action of humanin and humanin analogues: research findings and perspectives
Ocular adverse events associated with GLP-1 receptor agonists: a real-world study based on the FAERS database and network pharmacology
Cognitive-behavioral therapy techniques help clients identify and modify problematic story patterns, developing more balanced and realistic narratives about themselves and their experiences
US$ 26.43
US$ 26.69
US$ 22.75
US$ 29.60
US$ 21.04
US$ 20.74
US$ 22.68
US$ 20.90
US$ 27.10
US$ 21.02
US$ 25.05
